Sie sind auf Seite 1von 1

National Actions

Global
Actions
Program Implementation
Preparation
(3-6 months before launch)
Vaccine Launch

Post-Launch

Monitoring and Evaluation
Discuss and reach
consensus to introduce
a new vaccine
Conduct nationwide
assessment of cold
chain storage space
and logistics
assessment
Update/prepare cMYP
and costing tables.
Incorporate into national
health sector plan
Develop plan for vaccine
introduction plan
Solicit ICC endorsement
and commitment for
implementation
Prepare or revise GAVI
application, obtain
ministerial signatures,
and submit on time.
Country
submits/
re-submits
application
IRC makes
recommend-
ation to the
GAVI Board

GAVI
Secretariat
prioritizes
applications
for approval
Upgrade cold chain
and logistics
Advocate for vaccine
introduction support and
long term funding
Register the vaccine,
review vaccine supply
distribution system,
upgrade as needed
Revise, print and
distribute EPI
management tools
Develop/adapt learning
materials, conduct
technical training
As needed, improve
waste management
system
Implement demand
creation for new vaccine
Initiate AEFI
surveillance for the new
vaccine and strengthen
AEFI reporting system
Develop communications
strategies and key
messages to address
concerns of caregivers and
providers
Hold public
relations
events to
launch the
vaccine
Monitoring
and response
to any reported
adverse events
Conduct post-
introduction
evaluation (PIE)
6-12 months
following vaccine
launch
Reduced
morbidity
and
mortality
due to the
targeted
vaccine
preventable
disease
Assess magnitude of
problem: morbidity and
mortality due to target
disease for new vaccine
Scale Up Map for New Vaccine Introduction in GAVI supported countries*
V
a
c
c
i
n
a
t
e

a
l
l

e
l
i
g
i
b
l
e

p
e
o
p
l
e

Assess impact on
morbidity and
mortality
Source: MCHIP 2014
Continuous
monitoring,
supervision
capacity building,
and follow up to
ensure full
integration into
the RI system
* MCHIP-assisted
activities are in
boxes outlined in
red
Initiate surveillance to
establish baseline.
Select specific vaccine
product suitable for
country context.

Das könnte Ihnen auch gefallen